Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Search content at Mayo Clinic
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Effect of hyperglycemia on human monocyte activation
Debashis Nandy
, Rajiv Janardhanan
,
Debabrata Mukhopadhyay
, Ananda Basu
Jacksonville, FL
Endocrinology, Diabetes, Metabolism, and Nutrition
Research output
:
Contribution to journal
›
Article
›
peer-review
22
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Effect of hyperglycemia on human monocyte activation'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Human Monocytes
100%
Hyperglycemia
100%
Monocyte Activation
100%
Glucose Concentration
66%
Monocytes
50%
Chemokines
50%
Phosphorylation
33%
Phosphoinositide 3-kinase (PI3K)
33%
Monocyte Migration
33%
Kinase Inhibitor
16%
Basal Level
16%
Endothelial Monolayer
16%
Migration Assay
16%
Per Se
16%
Pre-diabetes (pre-DM)
16%
Glycogen Synthase Kinase
16%
THP-1 Cells
16%
Human Umbilical Vein Endothelial Cells (HUVECs)
16%
Transmigration
16%
P110
16%
Adhesion Test
16%
Stress Fibers
16%
Fiber Response
16%
Transmigration Assay
16%
Monocyte Adhesion
16%
P101
16%
Adhesion/migration
16%
Medicine and Dentistry
Hyperglycemia
100%
Monocyte
100%
Glucose
77%
Chemokine
33%
phosphorylation
22%
Diabetes Mellitus
11%
Phosphoinositide 3-Kinase
11%
Glycogen Synthase Kinase
11%
Phosphoinositide 3-Kinase Inhibitor
11%
THP1 Cell Line
11%
Human Umbilical Vein Endothelial Cell
11%
Stress Fiber
11%
Immunology and Microbiology
Monocyte
100%
Glucose
77%
Chemokine
33%
Kinase
33%
Phosphotransferase
33%
phosphorylation
22%
THP-1 Cell Line
11%
Umbilical Vein Endothelial Cell
11%
P110δ
11%
Stress Fiber
11%
Glycogen
11%